Clinical Trial Update: Multicenter Postmarket Surveillance Registry Evaluating Performance and Long Term Safety of the Presillion Stent

View source ↗

Summary

A multicenter postmarket registry assessing the performance and long-term safety of the Presillion Stent in coronary arteriosclerosis, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Arteriosclerosis

Drugs mentioned

• Presillion Stent (stent)

Snippet

Sponsor: Johnson and Johnson, S.A. | Conditions: Coronary Arteriosclerosis | Status: COMPLETED | Results posted: 2013-03-06